|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, April 19, 2018 ) Global Intravenous Ibuprofen Market was worth USD 5.72 billion in 2017 and estimated to be growing at a CAGR of 20.0%, to reach USD 14.23 billion by 2022. Ibuprofen is a Non steroidal anti-Inflammatory drug used to treat pain and fever which can be causative of a disease, trauma or any major operation. In an intravenous form, the drug has a faster onset of action as compared to other forms. IV Ibuprofen is used to manage acute and post-operative pain.
Browse full report @ https://marketdataforecast.com/market-reports/intravenous-ibuprofen-market-6729/
Due to its faster onset of action and fast results, the market is expected to grow at a rapid rate during the forecast period. As it has been approved for paediatric use, the market is further expected to propel. Due to increased incidence of cardiovascular diseases, cancer and fever coupled with shifting trend to non-opoid drugs is further driving the market growth. However, the side effects associated with the use of ibuprofen and the lengthy approval processes are hampering the market growth.
Get free sample report @ https://marketdataforecast.com/market-reports/intravenous-ibuprofen-market-6729/request-sample
The market for Intravenous Ibuprofen is broadly categorized into age group and indication. By age group the market is divided into adults and paediatrics. Adults are the major consumer base for intravenous ibuprofen. The paediatric segment is expected to grow at a substantial rate. By indication the market is further classified into fever and pain/inflammatory. Fever is projected to be the fastest growing segment. On the basis of geography, the market is analysed under various regions namely North America, Europe, Asia-Pacific and Rest of the World. The Intravenous Ibuprofen market was dominated by North America. Asia Pacific is expected to grow at a high CAGR.
Buy now @ https://marketdataforecast.com/cart/buy-now/intravenous-ibuprofen-market-6729/
Some of the major companies dominating the market, by their products and services include Cumberland Pharmaceuticals Inc., Alveda Pharmaceuticals, Inc., CSL Limited, Sandor Medicaids Pvt Ltd., Germin MED, Grifols S.A., Harbin Gloria Pharmaceuticals Co., Ltd., Al Nabeel International Ltd., PT. Soho Industri Pharmasi, and Laboratorios Valmorca, C.A.
About Market Data Forecast™
Market Data Forecast is a market research firm offering syndicated research, consults and industry newsletters across various domains & verticals. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for the majority of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest. Our experience and in-depth understanding of various business environments will be a support to you and your organization in making well-informed decisions
Market Data Forecast.
Abhishek Shukla
+1-888-702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
